Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Organon Canada Gets Approval For NDUVRA 1% Non-Steroid Cream For Atopic Dermatitis

(RTTNews) - Organon Canada, a subsidiary and regional affiliate of Organon & Co. (OGN) announced on Monday the approval of NDUVRA or Tapinarof cream, 1%, a new steroid-free topical treatment for moderate to severe atopic dermatitis in adult and pediatric patients of two years and

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Monday 28 September →